XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net loss $ (20,360) $ (12,738)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 429 462
Stock-based compensation 2,368 1,513
Warrant change in fair value (875) 165
Increase in accounts receivable (800) (1,666)
Decrease (increase) in other current assets 4,923 (1,076)
Increase in accounts payable 2,061 7,030
(Decrease) increase in deferred revenues 1,160 (2,878)
Decrease in accrued expenses and other current liabilities (1,837) (447)
Increase in other long-term liabilities 105 0
Net cash used in operating activities (15,146) (3,879)
Cash flows from investing activities:    
Purchase of property and equipment (88) (319)
Net cash used in investing activities (88) (319)
Cash flows from financing activities:    
Payment of deferred issuance costs 0 75
Proceeds from exercise of stock options 2,063 797
Payments for employee taxes withheld related to vested stock-based awards 558 0
Net cash provided by financing activities 1,505 722
Net decrease in cash and cash equivalents (13,729) (3,476)
Cash and cash equivalents at the beginning of the period 198,256 13,248
Cash and cash equivalents at the end of the period [1] 184,527 9,772
Supplemental cash flow data:    
Cash paid during the period for interest 12 5
Cash paid during the period for income taxes 174
Non-Cash financing activities:    
Deferred issuance costs 0 2,673
Issuance of warrant and other costs related to the Credit Agreement $ 0 $ 175
[1] As of March 31, 2022, amount includes restricted cash of $0.4 million maintained in a short-term certificate of deposit account and included within other current assets in the condensed consolidated balance sheet.